CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) IMAGE: ALEJO EFEYAN AND ANA ORTEGA- MOLINA. /CNIO CREDIT: CNIO For their own benefit and to grow beyond control, tumors manipulate cell signals to make it appear as if the cells have the nutrients they need. That is the case in follicular lymphoma, a type of tumor that affects...
Ana Jiménez-Ubieto, M.D., Ph.D., from the Hospital Universitario 12 de Octubre in Madrid, and colleagues examined whether ASCT is an effective option in the pre-rituximab era for patients treated in induction and rescued only with chemotherapy. Two groups were identified: the ETF cohort (87 patients) and the non-ETF cohort (47 patients). The researchers found that five-year progression-free...
